Retraction: Inhibition of hmgb1-induced angiogenesis by cilostazol via sirt1 activation in synovial fibroblasts from rheumatoid arthritis (PLoS ONE (2014) 9:8 (e104743) DOI: 10.1371/journal.pone.0104743);Inhibition of HMGB1-induced angiogenesis by cilostazol via SIRT1 activation in synovial fibroblasts from rheumatoid arthritis

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Kim, Hye Young ^a   Park, So Youn ^a   Lee, Sung Won ^c   Lee, Hye Rin ^a   Lee, Won Suk ^a,b   Rhim, Byung Yong ^b   Hong, Ki Whan ^a   Kim, Chi Dae ^a,b  

^a Pusan National University   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

^c Dong A University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; CD31 ANTIGEN; CILOSTAZOL; HIGH MOBILITY GROUP B1 PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN ANTIBODY; RESVERATROL; SIRTINOL; SIRTUIN 1; SIRTUIN 1 DEACETYLASE; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; VASCULOTROPIN; VON WILLEBRAND FACTOR ANTIBODY; ANGIOGENESIS INHIBITOR; TETRAZOLE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; BLOOD VESSEL; CONTROLLED STUDY; DEACETYLATION; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPOSURE; FIBROBLAST; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; KNEE; MALE; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NONHUMAN; PROTEIN DNA BINDING; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIAL FIBROBLAST; WESTERN BLOTTING; ANIMAL; ARTHRITIS, RHEUMATOID; CELL CULTURE; COMPLICATION; CYTOLOGY; DRUG EFFECTS; IMMUNOLOGY; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; SYNOVIUM;

ANGIOGENESIS INHIBITORS; ANIMALS; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; FIBROBLASTS; HMGB1 PROTEIN; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MICE; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; SIRTUIN 1; SYNOVIAL MEMBRANE; TETRAZOLES;

EID: 84938235827     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0230889     Document Type: Erratum

References (31)

1. Distler JH, Wenger RH, Gassmann M, Kurowska M, Hirth A, et al. (2004) Physiologic responses to hypoxia and implications for hypoxia-inducible factors in the pathogenesis of rheumatoid arthritis. Arthritis Rheum 50: 10-23. (Pubitemid 38084283)
2. Muz B, Khan MN, Kiriakidis S, Paleolog EM (2009) Hypoxia. The role of hypoxia and HIF-dependent signalling events in rheumatoid arthritis. Arthritis Res Ther 11: 201-209.
3. Semenza GL (2007) Vasculogenesis, angiogenesis, and arteriogenesis: mechanisms of blood vessel formation and remodeling. J Cell Biochem 102: 840-847.
4. Thornton RD, Lane P, Borghaei RC, Pease EA, Caro J, et al. (2000) Interleukin 1 induces hypoxia-inducible factor 1 in human gingival and synovial fibroblasts. Biochem J 350: 307-312.
5. Westra J, Brouwer E, Bos R, Posthumus MD, Doornbos-van der Meer B, et al. (2007) Regulation of cytokine-induced HIF-1alpha expression in rheumatoid synovial fibroblasts. Ann N Y Acad Sci 1108: 340-348. (Pubitemid 47528746)
6. Andersson U, Erlandsson-Harris H (2004) HMGB1 is a potent trigger of arthritis. J Intern Med 255: 344-350. (Pubitemid 38315275)
7. Scaffidi P, Misteli T, Bianchi ME (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418: 191-195. (Pubitemid 34773774)
8. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, et al. (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248-251. (Pubitemid 29329996)
9. Taniguchi N, Kawahara K, Yone K, Hashiguchi T, Yamakuchi M, et al. (2003) High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum 48: 971-981. (Pubitemid 36418239)
10. Hamada T, Torikai M, Kuwazuru A, Tanaka M, Horai N, et al. (2008) Extracellular high mobility group box chromosomal protein 1 is a coupling factor for hypoxia and inflammation in arthritis. Arthritis Rheum 58: 2675-2685.
11. van Beijnum JR, Buurman WA, Griffioen AW (2008) Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis 11: 91-99.
12. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, et al. (1996) Activation of vascular endothelial growth factor gene transcription by HIF-1. Mol Cell Biol 16: 4604-4613. (Pubitemid 26272112)
13. Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, et al. (1998) Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394: 485-490. (Pubitemid 28373960)
14. Shin HK, Kim YK, Kim KY, Lee JH, Hong KW (2004) Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol. Circulation 109: 1022-1028. (Pubitemid 38282856)
15. Park SY, Lee JH, Kim YK, Kim CD, Rhim BY, et al. (2005) Cilostazol prevents remnant lipoprotein particle-induced monocyte adhesion to endothelial cells by suppression of adhesion molecules and monocyte chemoattractant protein-1 expression via lectin-like receptor for oxidized low-density lipoprotein receptor activation. J Pharmacol Exp Ther 312: 1241-1248.
16. Park SY, Lee JH, Kim CD, Lee WS, Park WS, et al. (2006) Cilostazol suppresses superoxide production and expression of adhesion molecules in human endothelial cells via mediation of cAMP-dependent protein kinase-mediated maxi-K channel activation. J Pharmacol Exp Ther 317: 1238-1245.
17. Park SY, Lee SW, Shin HK, Chung WT, Lee WS, et al. Cilostazol enhances apoptosis of synovial cells from rheumatoid arthritis patients with inhibition of cytokine formation via Nrf2-linked heme oxygenase 1 induction. Arthritis Rheum 62: 732-741.
18. Lim JH, Lee YM, Chun YS, Chen J, Kim JE, et al. (2010) Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Mol Cell 38: 864-878.
19. Chun YS, Yeo EJ, Choi E, Teng CM, Bae JM, et al. (2001) Inhibitory effect of YC-1 on the hypoxic induction of erythropoietin and vascular endothelial growth factor in Hep3B cells. Biochem Pharmacol 61: 947-954. (Pubitemid 32247383)
20. Kung AL, Zabludoff SD, France DS, Freedman SJ, Tanner EA, et al. (2004) Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway. Cancer Cell 6: 33-43. (Pubitemid 38903160)
21. Pierce JW, Schoenleber R, Jesmok G, Best J, Moore SA, et al. (1997) Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 272: 21096-21103. (Pubitemid 27373968)
22. van Uden P, Kenneth NS, Rocha S (2008) Regulation of hypoxia-inducible factor-1α by NF-κB. Biochem J 412: 477-484.
23. Mollica L, De Marchis F, Spitaleri A, Dallacosta C, Pennacchini D, et al. (2007) Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities. Chem Biol 14: 431-441. (Pubitemid 46617319)
24. Kokkola R, Li J, Sundberg E, Aveberger AC, Palmblad K, et al. (2003) Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum 48: 2052-2058. (Pubitemid 36828701)
25. Del Rey MJ, Izquierdo E, Usategui A, Gonzalo E, Blanco FJ, et al. (2010) The transcriptional response of normal and rheumatoid arthritis synovial fibroblasts to hypoxia. Arthritis Rheum 62: 3584-3594.
26. 2 tension. Proc Natl Acad Sci USA 92: 5510-5514.
27. Torii S, Okamura N, Suzuki Y, Ishizawa T, Yasumoto K, et al. (2009) Cyclic AMP represses the hypoxic induction of hypoxia-inducible factors in PC12 cells. J Biochem 146: 839-844.
28. Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, et al. (1994) Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 152: 4149-4156. (Pubitemid 24111088)
29. Paleolog EM, Young S, Stark AC, McCloskey RV, Feldmann M, et al. (1998) Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis. Arthritis Rheum 41: 1258-1265. (Pubitemid 28313429)
30. Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, et al. (2008) NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453: 807-811. (Pubitemid 351793778)
31. Neidhart M, Seemayer CA, Hummel KM, Michel BA, Gay RE, et al. (2003) Functional characterization of adherent synovial fluid cells in rheumatoid arthritis: destructive potential in vitro and in vivo. Arthritis Rheum 48: 1873-1880. (Pubitemid 36828682) Technology